Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to fall 41.40% to -23 cents per share on November 19
Q3'26
Est.
$-0.23
Q2'26
Missed
by $0.18
Q1'26
Missed
by $0.24
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.17
The last earnings report on August 13 showed earnings per share of -39 cents, missing the estimate of -21 cents. With 6.99K shares outstanding, the current market capitalization sits at 539.55M.